| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Russell Steven Jon | Chief Medical Officer | C/O BETA BIONICS, INC., 11 HUGHES, IRVINE | /s/ Stephen Feider, Attorney-in-Fact | 16 Mar 2026 | 0002051384 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BBNX | Common Stock | Sale | $30,069 | -1,025 | -0.57% | $29.34 | 178,071 | 02 Dec 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. |